FDA Advisory Committee Debates Compounding Rights for Synthetic Peptides

By Meghana Keshavan · STAT News · 2026-07-23

FDA Advisory Committee Debates Compounding Rights for Synthetic Peptides

An FDA advisory committee began a two-day meeting to determine if compounding pharmacies should be permitted to produce seven specific synthetic peptides. According to reporting from STAT News, the decision involves a potential rift between agency scientists who prioritize clinic

An FDA advisory committee began a two-day meeting to determine if compounding pharmacies should be permitted to produce seven specific synthetic peptides. According to reporting from STAT News, the decision involves a potential rift between agency scientists who prioritize clinic